Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NLRP3 | Q96P20 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22534128 | 0.98 | KDM4E (0.50) | KDM4EMAPTBRD4LMNAMEN1 | |
| SCHEMBL13977549 | 0.97 | BRD4 (0.50) | KDM4EMAPTBRD4LMNAMEN1 | |
| SCHEMBL7678336 | 0.86 | KDM4E (0.42) | KDM4EMAPTBRD4LMNAMEN1 | |
| SCHEMBL16595631 | 0.85 | KDM4E (0.43) | KDM4EMAPTBRD4LMNAMEN1 | |
| SCHEMBL16595639 | 0.82 | USP2 (0.39) | KDM4EMAPTRAB9AKMT2ANPC1 | |
| SCHEMBL29282052 | 0.78 | KDM4E (0.44) | KDM4EMAPTBRD4MEN1KMT2A | |
| SCHEMBL19318769 | 0.77 | ALOX15 (0.45) | KDM4EMAPTBRD4LMNAMEN1 | |
| SCHEMBL24608876 | 0.76 | KDM4E (0.34) | KDM4EMAPTMEN1RAB9AKMT2A | |
| SCHEMBL15221347 | 0.76 | GRM1 (0.40) | KDM4EMAPTBRD4LMNAMEN1 | |
| SCHEMBL21579187 | 0.75 | ALDH1A1 (0.44) | KDM4ELMNAMEN1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113748184-B | Boron-containing cyclic light-emitting compound and color conversion film containing same | 日东电工株式会社 | 2025-04-04 | — | — | CN | disclosed |
| CN-115335488-A | Boron-containing cyclic luminescent compound and color conversion film comprising the same | 日东电工株式会社 | 2022-11-11 | — | — | CN | disclosed |
| US-20220216411-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORP (JP) | 2022-07-07 | — | — | US | disclosed |
| US-20220216411-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORP (JP) | 2022-07-07 | — | — | US | disclosed |
| WO-2021188762-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORPORATION (JP) | 2021-09-23 | — | — | WO | disclosed |
| US-20210093239-A1 | OXYGEN SENSORS | PROFUSA, INC. (US) | 2021-04-01 | — | — | US | disclosed |
| EP-3797798-A1 | OXYGEN SENSORS | Profusa, Inc. (US) | 2021-03-31 | — | — | EP | disclosed |
| US-10874337-B2 | Oxygen sensors | PROFUSA, INC. (US) | 2020-12-29 | — | — | US | disclosed |
| WO-2020210761-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORPORATION (JP) | 2020-10-15 | — | — | WO | disclosed |
| WO-2020210761-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORPORATION (JP) | 2020-10-15 | — | — | WO | disclosed |
| US-20050176802-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | SUGEN, INC. & PHARMACIA & UPJOHN CO. | 2005-08-11 | — | — | US | disclosed |
| WO-2005066135-A2 | PYRROLE AND PYRAZOLE DAAO INHIBITORS | SEPRACOR INC. (US) | 2005-07-21 | — | — | WO | disclosed |
| US-20050143443-A1 | Pyrrole and pyrazole DAAO inhibitors | SEPRACOR INC. (US) | 2005-06-30 | — | — | US | disclosed |
| US-6878733-B1 | Formulations for pharmaceutical agents ionizable as free acids or free bases | SUGEN, INC. (US) | 2005-04-12 | — | — | US | disclosed |
| US-20040063773-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | SUGEN, INC. & PHARMACIA & UPJOHN CO. | 2004-04-01 | — | — | US | disclosed |
| US-20030216410-A1 | Combination therapy for the treatment of cancer | PHARMACIA CORPORATION | 2003-11-20 | — | — | US | disclosed |
| US-6573293-B2 | Pyrrole substituted 2-indolinone protein kinase inhibitors | SUGEN, INC. | 2003-06-03 | — | — | US | disclosed |
| US-20020156292-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | PHARMACIA & UPJOHN COMPANY LLC | 2002-10-24 | — | — | US | disclosed |
| EP-1233943-A2 | IONIZABLE INDOLINONE DERIVATIVES AND THEIR USE AS PTK LIGANDS | Sugen, Inc. (US) | 2002-08-28 | — | — | EP | disclosed |
| WO-2001037820-A2 | IONIZABLE INDOLINONE DERIVATIVES AND THEIR USE AS PTK LIGANDS | SUGEN, INC. (US) | 2001-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216410-A1 | Combination therapy for the treatment of cancer | PTGS2, PTGES2, PTGFR | KDM4E 2807/4885MAPT 4505/4885BRD4 1108/4885 |
| US-20220216411-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | BLVRB, CLTB, CRY1 | KDM4E 1084/4885MAPT 497/4885BRD4 68/4885 |
| US-20050176802-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | PDPK1, MAP3K20, PLK2 | KDM4E 1307/4885MAPT 1881/4885BRD4 695/4885 |
| US-20210093239-A1 | OXYGEN SENSORS | COXFA4L2, PPOX, EGLN3 | KDM4E 2173/4885MAPT 3747/4885BRD4 3249/4885 |
| US-20050143443-A1 | Pyrrole and pyrazole DAAO inhibitors | DDO, DAO, SRR | KDM4E 1764/4885MAPT 1403/4885BRD4 1860/4885 |
| US-10874337-B2 | Oxygen sensors | COXFA4L2, PPOX, EGLN3 | KDM4E 2173/4885MAPT 3747/4885BRD4 3249/4885 |
| US-20040063773-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | PDPK1, MAP3K20, PLK2 | KDM4E 1307/4885MAPT 1881/4885BRD4 695/4885 |
| US-20020156292-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | PDPK1, MAP3K20, PLK2 | KDM4E 1307/4885MAPT 1881/4885BRD4 695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.